Welcome to In the Spotlight, where each month we shine a light on something exciting, timely, or simply fascinating from the world of science.
In honor of Alzheimer's Awareness Month, we’re exploring the science and stories surrounding Alzheimer’s disease.
Latest News Releases
Updates every hour. Last Updated: 21-Oct-2026 08:15 ET (21-Oct-2026 12:15 GMT/UTC)
Optical imaging links altered metabolism and oxygen use in Alzheimer’s disease
SPIE--International Society for Optics and PhotonicsPeer-Reviewed Publication
- Journal
- Neurophotonics
Who gets Alzheimer’s drugs? Race, vulnerability and health status shape access
Michigan Medicine - University of MichiganPeer-Reviewed Publication
A Michigan Medicine study found major disparities in access to new Alzheimer’s drugs, with Black and Hispanic patients less likely to receive treatment, though adherence was similar once therapy began.
- Journal
- Neurology
- Funder
- American Academy of Neurology
Upstate receives $1.5 million to advance brain disease research
State University of New York Upstate Medical UniversityGrant and Award Announcement
Upstate Medical University has received $1.5 million in state funding as part of the SUNY Brain Institute, a $10 million collaborative effort to strengthen neuroscience research across SUNY campuses. The investment will expand New York’s capacity to study Alzheimer’s disease, Parkinson’s disease, stroke, and other age-related brain disorders by connecting researchers, specialized equipment, and advanced research infrastructure. At Upstate, the funding will support development of patient-derived stem cell and brain organoid models that more closely replicate human disease, helping researchers better understand disease progression and evaluate potential treatments. The initiative is designed to accelerate discovery, foster collaboration across institutions, and address the growing burden of neurological diseases on New Yorkers as the population ages.
- Funder
- State University of New York
New drug-delivery method offers promise in fight against neurodegenerative diseases
University of OttawaPeer-Reviewed Publication
- Journal
- Nature Biomedical Engineering
- Funder
- Canadian Institutes of Health Research
In Alzheimer’s disease, the brain’s pacemaker cells lose their beat
Gladstone InstitutesPeer-Reviewed Publication
In a study published in Neuron, scientists at Gladstone Institutes discovered that specialized rhythm-keeping cells called parvalbumin (PV) interneurons generate these brain rhythms by taking precise turns firing. But in mouse models of Alzheimer's disease, this delicate coordination collapses, causing memory waves to falter.
- Journal
- Neuron
- Funder
- Ray and Dagmar Dolby Family Fund, Cure Alzheimer's Fund, Simon Family Trust, Alzheimer's Association, Texas Alzheimer's Research and Care Consortium